Market revenue in 2023 | USD 8,520.8 million |
Market revenue in 2030 | USD 10,877.8 million |
Growth rate | 3.6% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Medical Microbiology & Cytology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 62.79% in 2023. Horizon Databook has segmented the Middle East & Africa clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA market includes South Africa, Saudi Arabia, and other Middle Eastern & North African countries. Market growth in this region can be attributed to the steady development of healthcare facilities in emerging economies and increasing healthcare expenditure.
The emergence of this region as a major investor has led to an increase in diagnostics manufacturers in countries such as South Africa, the UAE, and Saudi Arabia. Most of the tests and medical facilities are stable due to a regulatory scenario that favors infrastructure development and reimbursement, which is mostly regulated by the government.
High prevalence of lifestyle-associated diseases in the region is expected to boost the demand for clinical laboratory services. Furthermore, increasing awareness about early diagnosis of diseases is anticipated to drive the market. The COVID-19 pandemic has further boosted investments and development of clinical laboratories in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa clinical laboratory service market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account